Hyperoxemia is a condition when there is an increase in level of arterial oxygen partial pressure (PaO2) to a greater extent upto 120mHg. Hyperoxemia generally occurs when the tissues, cells and organs are exposed to excess oxygen supply or higher than normal oxygen partial pressure. Hyperoxemia is caused by hyperoxia which is mostly seen in 50% of mechanically ventilated patient’s cases. Hyperoxemia treatment is done by prescribing oxygen supplementation to get relieve from arterial Hyperoxemia. Supplementation of oxygen is most common therapy for the hyperoxemia treatment in critically ill patients. Many patients respond to the supplementation of excess oxygen which is given by nasal cannula. As soon as the oxygen level reaches to normal, the prognosis of the hyperoxemia treatment is better. Until now there is no alternative to hyperoxemia treatment other than supplementation of oxygen. In addition to this, hyperoxemia treatment can also be done by hyperbaric chamber which increases the concentrations of oxygen in the blood. Moreover, hyperoxemia treatment can also be provided by mechanical ventilation whereby the supply of oxygen is higher than the normal atmospheric concentrations. Hyperoxemia treatment generally used oxygen delivery devices such as blow-by oxygen, oxygen hood or tent, low-flow nasal cannula, high-flow nasal cannula, oxygen mask, mechanical ventilation etc. Oxygen therapy is indicated when there occurs low concentration of oxygen within the arterial blood.
The global hyperoxemia treatment market is expected to register significant growth in the market since there is only one therapy given to the patients in hyperoxemia treatment. Supplementation of oxygen is the sole therapy for the hyperoxemia treatment. In addition to this, hyperoxemia treatment also helps in detecting the cardiac arrest which as a result, there seems to have great use of hyperoxemia treatment market. However, the risk associated with oxygen therapy and the cost may restrain the growth of the hyperoxemia treatment market. Many clinical trials are ongoing globally for the hyperoxemia treatment. Couple of studies done for the hyperoxemia treatment observed transient improvement with high supplementation of oxygen in clinical deficits after ischemic stroke and all other studies revealed no positive association between hyperoxemia and outcome such as functional recovery, mortality and functional recovery. Since clinical studies has been ongoing in hyperoxemia treatment, the market is likely to anticipate growth in coming years. With the advancement in research and development, the hyperoxemia treatment market will significantly spur the growth of the market.
The global hyperoxemia treatment market is segmented on the basis of indication and end user
- Market Segmentation by Indication
- Tissue necrosis
- Metabolic acidosis
- Market Segmentation by End User
- Ambulatory Surgical Centers
- Speciality Clinics
Geographically, hyperoxemia treatment market is categorized into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America seems to have greater share in terms of revenue in hyperoxemia treatment market owing to advance in research and development, improved medications and increase use of modern equipped instruments in laboratories and hospitals is likely to generate substantial revenue in the hyperoxemia treatment market. Europe also seems to have significant contribution to the growth of hyperoxemia treatment market owing to increase in adoption of advanced instruments and rising prevalence of hyperoxemia which is likely to witness growth in the hyperoxemia treatment market. Asia Pacific also have the potential to spur the growth of the hyperoxemia treatment market due to increasing demand of new treatment option and rising awareness among people about hyperoxemia will stimulate the growth of the hyperoxemia treatment market. Middle East and Africa have less potential in hyperoxemia treatment market due to poor economy and lack of proper healthcare facilities.
Some of the key players leading in hyperoxemia treatment market are: Mercury Medical, Ningbo David Medical Device Co., Ltd, Olidef, Natus Medical, Ginevri, Medin, Vapotherm, Inc., Fanem Ltda, GaleMed Corporation, Gigante Recém Nascido, Zhengzhou Dison Instrument And Meter, nice Neotech Medical Systems, Farstar (Wuxi) Medical Equipment, SS Technomed.
The report covers exhaustive analysis on:
- Hyperoxemia Treatment Market Segments
- Hyperoxemia Treatment Market Dynamics
- Historical Actual Market Size, 2014 - 2018
- Hyperoxemia Treatment Market Size & Forecast 2019 to 2029
- Hyperoxemia Treatment Current Trends/Issues/Challenges
- Competition & Companies involved
- Hyperoxemia Treatment Market Drivers and Restraints
Regional analysis includes
- North America
- Latin America
- Asia Pacific
- Middle East & Africa
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size Recent industry trends
- Key Competition landscape
- Strategies for key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance